1-20 of 2077
Clinical Trials and Observations
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

Open Access
Clinical Trials & Observations
Nicholas J. Short, Hagop Kantarjian, Nitin Jain, Tapan M. Kadia, Jayastu Senapati, Fadi G. Haddad, Manuel M. Maroun, Koji Sasaki, Lianchun Xiao, Xuelin Huang, Omer Karrar, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Elias Jabbour
Journal: Blood Advances
Blood Adv (2026) 10 (1): 25–28.
https://doi.org/10.1182/bloodadvances.2025016565
Published: 2026
Includes: Supplemental data
Journal Articles

Safety and efficacy of daratumumab in immune thrombocytopenia

Open Access
Clinical Trials & Observations
Galina Tsykunova, Pål Andre Holme, Hoa Thi Tuyet Tran, Henrik Frederiksen, Eirik Tjønnfjord, Ludvig A. Munthe, Elsa Drivet, Hassen Kared, Ingvild Hausberg Sørvoll, Maria Therese Ahlen, Matthiéu Mahévas, Marc Michel, James Bussel, David J. Kuter, Tor Henrik Anderson Tvedt, Waleed Ghanima
Journal: Blood Advances
Blood Adv (2026) 10 (1): 143–154.
https://doi.org/10.1182/bloodadvances.2025017279
Published: 2026
Includes: Supplemental data
Journal Articles

BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant

Open Access
Clinical Trials & Observations
Dimana Dimitrova, Elisabetta Xue, Mustafa A. Hyder, Hyoyoung Choo-Wosoba, Kamil Rechache, Francis A. Flomerfelt, Sanchita Das, Christi McKeown, Alison Cusmano, Ruby Sabina, Jennifer A. Kanakry, Christopher G. Kanakry
Journal: Blood Advances
Blood Adv (2026) 10 (1): 1–13.
https://doi.org/10.1182/bloodadvances.2025016589
Published: 2026
Includes: Supplemental data
Journal Articles

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years

Open Access
Clinical Trials & Observations
Anna C. Ferreira, Debjani Dutta, Courtney M. Rowan, Jamie Renbarger, Kenneth R. Cooke, Paul A. Carpenter, Robert Krance, Christine Duncan, C. Russell Y. Cruz, David Jacobsohn, Catherine M. Bollard, Elizabeth Hill, Sophie Paczesny
Journal: Blood Advances
Blood Adv (2026) 10 (1): 168–180.
https://doi.org/10.1182/bloodadvances.2025016624
Published: 2026
Includes: Supplemental data
Journal Articles

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma

Open Access
Clinical Trials & Observations
Keri Toner, Lindsay A. Renfro, Hema Dave, Gloria Pezzella, Qinglin Pei, Lisa Giulino-Roth, Terzah Horton, Frank G. Keller, Kara M. Kelly, Sharon M. Castellino, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2026) 10 (1): 183–191.
https://doi.org/10.1182/bloodadvances.2025016797
Published: 2026
Includes: Supplemental data
Journal Articles

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Open Access
Clinical Trials & Observations
Kelly E. Faulk, John A. Kairalla, Emily Hibbitts, Janel Long-Boyle, Meenakshi Devidas, Amanda August, Lia Gore, Elizabeth Raetz, Stephen P. Hunger, Mignon L. Loh, David T. Teachey, Patrick Brown, Erin H. Breese, Rishi S. Kotecha, Erin Guest
Journal: Blood Advances
Blood Adv (2026) 10 (1): 70–74.
https://doi.org/10.1182/bloodadvances.2025017013
Published: 2026
Includes: Supplemental data
Journal Articles

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group

Open Access
Clinical Trials & Observations
Marion Aymard, Morgane Cheminant, Roch Houot, Anne Cuozzo, Elodie Gat, Catherine Thieblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stéphanie Guidez, Amandine Fayard, Gabriel Brisou, Loic Ysebaert, Olivier Hermine, Benoît Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy
Journal: Blood Advances
Blood Adv (2026) 10 (1): 75–82.
https://doi.org/10.1182/bloodadvances.2025017234
Published: 2026
Includes: Supplemental data
Journal Articles

Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care

Open Access
Clinical Trials & Observations
Hiroyuki Matsui, Yasuyuki Arai, Junya Kanda, Tadakazu Kondo, Michelle L. Schoettler, Mohamad Mohty, Miguel-Angel Perales, Rafael F. Duarte, Alessandro Rambaldi, Akifumi Takaori-Kondo
Journal: Blood Advances
Blood Adv (2026) 10 (1): 111–120.
https://doi.org/10.1182/bloodadvances.2025017540
Published: 2026
Journal Articles

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium

Open Access
Clinical Trials & Observations
Megan Melody, Natalie Grover, Stephanie Franco, Jason Romancik, Matthew Cortese, Tamara K. Moyo, Rahul S. Bhansali, Thomas Ollila, Vaishalee Kenkre, Lindsey Fitzgerald, Brian Hess, Matt Matasar, Geoffrey Shouse, Kaitlin Annunzio, Megan M. Herr, James A. Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Shuo Ma, Jane N. Winter, Adam Lin, Alexey Danilov, Ishan Roy, Stefan K. Barta, Leo I Gordon, Deborah Stephens, Jonathon B. Cohen, Narendranath Epperla, Reem Karmali
Journal: Blood Advances
Blood Adv (2026) 10 (1): 228–232.
https://doi.org/10.1182/bloodadvances.2025016968
Published: 2026
Journal Articles

Targeting the lectin pathway in TA-TMA

Open Access
Clinical Trials & Observations
Sonata Jodele
Journal: Blood Advances
Blood Adv (2026) 10 (1): 181–182.
https://doi.org/10.1182/bloodadvances.2025018551
Published: 2026
Journal Articles

Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma

Open Access
Clinical Trials & Observations
Emilie Charton, Amélie Anota, Emmannuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Obéric, Thomas Gastinne, Pierre Feugier, Remy Dulery, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, René-Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques-Olivier Bay, Francisco Llamas Gutierrez, Cedric Portugues, Emmanuel Itti, Xavier Palard-Novello, Paul Blanc-Durand, Yassine Al Tabaa, Clement Bailly, Camille Laurent, François Lemonnier, Roch Houot
Journal: Blood Advances
Blood Adv bloodadvances.2025018057.
https://doi.org/10.1182/bloodadvances.2025018057
Published: 2026
Includes: Supplemental data
Journal Articles

Zamtocabtagene Autoleucel in Relapsed/refractory B-NHL: 5-year Follow Up of a CD20/19 tandem CAR T Cell Phase 1 Trial

Open Access
Clinical Trials & Observations
Hyatt Balke-Want, Philipp Gödel, Christoph Schmid, Francis Ayuketang Ayuk, Birte Friedrichs, Pearl van Heteren, Silke Holtkamp, Gregor Zadoyan, Corinne Brillant, Joana Costa, Linda Hanssens, Tatjana Holzer, Christian Wöhle, Stefanie Biedermann, Iris Bürger, Rimas J Orentas, Toon Overstijns, Christoph Scheid, Udo Holtick, Stefan Miltenyi, Michael J Hallek, Peter Borchmann, Nadine Kutsch
Journal: Blood Advances
Blood Adv bloodadvances.2025018073.
https://doi.org/10.1182/bloodadvances.2025018073
Published: 2026
Includes: Supplemental data
Journal Articles

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Open Access
Clinical Trials & Observations
Talha Badar, Ludovica Marando, Eric Latorre-Crespo, Terra L Lasho, Francyess Denis Oliva, Chenyu Lin, Benjamin J. McCormick, Mobachir El Kettani, Kashish Shah, Yael N Kusne, Omer Jamy, Kendall Diebold, Alexander Coltoff, Christy M. Finke, James M. Foran, Mohamed A. Kharfan-Dabaja, Yao-Shan Fan, Liuyan Jiang, Rong He, Miles Thomas, Anand A Patel, David S. Viswanatha, Mithun Vinod Shah, Antoine N Saliba, Abhishek A. Mangaonkar, Kristina Kirschner, Aref Al-Kali, Naseema Gangat, Mark R. Litzow, Mrinal M Patnaik
Journal: Blood Advances
Blood Adv bloodadvances.2025018031.
https://doi.org/10.1182/bloodadvances.2025018031
Published: 2026
Includes: Supplemental data
Journal Articles

Concizumab in hemophilia with inhibitors: Longer-term efficacy and safety results from the phase 3 explorer7 study

Open Access
Clinical Trials & Observations
Johnny Mahlangu, Ana Boban, Maria Bruzelius, Giancarlo Castaman, Kingsley Kevin Hampton, Paul Knoebl, Aurélien Lebreton, Silvia Linari, Francisco Jose Lopez-Jaime, Camila Martins Mazini Tavares Tavares, Mohamed Salim Nekkal, Keiji Nogami, Amalie Rhode Høgh Nielsen, Amy D. Shapiro, Roseline D'Oiron
Journal: Blood Advances
Blood Adv bloodadvances.2025018264.
https://doi.org/10.1182/bloodadvances.2025018264
Published: 2026
Includes: Supplemental data
Journal Articles

Clinical applications of mass spectrometry in multiple myeloma

Open Access
Clinical Trials & Observations
Benjamin A. Derman, Andrew J. Yee
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6593–6603.
https://doi.org/10.1182/bloodadvances.2024015685
Published: 2025
Journal Articles

10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemia

Open Access
Clinical Trials & Observations
Alexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, Sara K Silbert, Hao-Wei Wang, Constance M. Yuan, Chloe N Hoang, August A Culbert, Flavia Gava, Monica S Nair, Victoria M Giordani, Lauren Little, Toni Foley, Veronique Nussenblatt, Terry J Fry, David F Stroncek, Steven L Highfill, Nirali N Shah
Journal: Blood Advances
Blood Adv bloodadvances.2025017753.
https://doi.org/10.1182/bloodadvances.2025017753
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Open Access
Clinical Trials & Observations
Ramón García-Sanz, Roger G. Owen, Wojciech Jurczak, Meletios A. Dimopoulos, Helen McCarthy, Gavin Cull, Stephen S. Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cleary Cohen, Constantine S. Tam
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6538–6546.
https://doi.org/10.1182/bloodadvances.2024015596
Published: 2025
Journal Articles

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis

Open Access
Clinical Trials & Observations
Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles, Jessica M. Stempel, Alain Mina, Lourdes Mendez, Tariq Kewan, Nikolai A. Podoltsev, Maximilian Stahl, Alyssa A. Grimshaw, Amer M. Zeidan, Jan Philipp Bewersdorf
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6511–6523.
https://doi.org/10.1182/bloodadvances.2025017611
Published: 2025
Includes: Supplemental data
Journal Articles

Sickle cell disease and thalassemia go to the PROm

Open Access
Clinical Trials & Observations
Miguel R. Abboud, Biree Andemariam
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6547–6548.
https://doi.org/10.1182/bloodadvances.2025017436
Published: 2025
Journal Articles

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel

Open Access
Clinical Trials & Observations
Akshay Sharma, Franco Locatelli, Monica Bhatia, Lyndsay Molinari, Markus Y. Mapara, Robert I. Liem, Laurence Dedeken, Donna Wall, Michael J. Eckrich, Kevin H. M. Kuo, Wally Smith, Suzan Imren, Puja Kohli, Nanxin Li, Tina Liu, Jaime Rubin, William Hobbs, Stephan A. Grupp, Haydar Frangoul
Journal: Blood Advances
Blood Adv (2025) 9 (24): 6481–6490.
https://doi.org/10.1182/bloodadvances.2025016701
Published: 2025
Includes: Supplemental data